nach oben

Neurological Sciences

Erschienen in:

02.10.2020 | Review Article

Relationship between bone disorders and stroke

verfasst von: Milija D. Mijajlovic, Vuk Aleksic, Natasa Stojanovski, Natan M. Bornstein

Erschienen in: Neurological Sciences | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Bone disorders are among the most uncommon causes of stroke, but they should be considered as stroke cause in particular clinical scenarios. On the other hand, osteoporosis/osteopenia and increased fracture risk are well documented post stroke complications. The relationship between stroke and bone health is complex. The current facts suggest that these two conditions share same risk factors, but also are risk factors for each other. However, the evidence shows more clear effect of stroke on the bone health, than in the opposite direction. This extensive review is aiming to fill the huge gap of evidence about this topic, and since bone pathology is extremely rare cause of cerebrovascular accident, although a complex connection between these two conditions definitely exists.

Myint PK, Poole KE, Warburton EA (2007) Hip fractures after stroke and their prevention. QJM. 100:539–545PubMed

Taal MW, Cassidy MJ, Pearson D, Green D, Masud T (1999) Usefulness of quantitative heel ultrasound compared with dual-energy X-ray absorptiometry in determining bone mineral density in chronic haemodialysis patients. Nephrol Dial Transplant. 14:1917–1921PubMed

Browner WS, Pressman AR, Nevitt MC, Cauley JA, Cummings SR (1993) Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke. 24:940–946PubMed

Mussolino ME, Madans JH, Gillum RF (2003) Bone mineral density and stroke. Stroke. 34:e20–e22PubMed

Nordström A, Eriksson M, Stegmayr B, Gustafson Y, Nordström P (2010) Low bone mineral density is an independent risk factor for stroke and death. Cerebrovasc Dis. 29:130–136PubMed

Chen YC, Wu JC, Liu L, Huang WC, Cheng H, Chen TJ et al (2013) Hospitalized osteoporotic vertebral fracture increases the risk of stroke: a population-based cohort study. J Bone Miner Res 28:516–523PubMed

Szulc P, Samelson EJ, Kiel DP, Delmas PD (2009) Increased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS study. J Bone Miner Res 24:2023–2031PubMedPubMedCentral

Jørgensen L, Engstad T, Jacobsen BK (2001) Bone mineral density in acute stroke patients: low bone mineral density may predict first stroke in women. Stroke. 32:47–51PubMed

Trivedi DP, Khaw KT (2001) Bone mineral density at the hip predicts mortality in elderly men. Osteoporosis Int. 12:259–265

10.

Browner WS, Lui LY (2001) Cummings SR (2001). Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab. 86:631–637PubMed

11.

Poole KE, Reeve J, Warburton EA (2002) Falls, fractures, and osteoporosis after stroke: time to think about protection? Stroke. 33(5):1432–1436PubMed

12.

Keene GS, Parker MJ, Pryor GA (1994) Mortality and morbidity after hip fractures. BMJ 307:1248–1250

13.

Schubert TA (1980) Fibrocartilaginous infarct in a German Shepherd dog. Vet Med Small Anim Clin. 75(5):839–842PubMed

14.

Ryan LM, Cheung HS, McCarty DJ (1981) Release of pyrophosphate by normal mammalian articular hyaline and fibrocartilage in organ culture. Arthritis Rheum. 24:1522–1527PubMed

15.

Uhthoff HK, Rahn BA (1981) Healing patterns of metaphyseal fractures. Clin Orthop Relat Res 160:295–303

16.

Kon M, de Visser AC (1981) A poly (HEMA) sponge for restoration of articular cartilage defects. Plast Reconstr Surg. 63:288–294

17.

Jeffrey M, Weels GA (1986) Multifocal ischemic encephalomyelopathy associated with fibrocartilaginous emboli in the lamb. Neuropathol Appl Neurobiol. 12(4):415–424PubMed

18.

Cook JR (1988) Fibrocartilaginous embolism. Vet Clin North Am Small Anim Pract. 18(3):581–592PubMed

19.

Johnson RC, Anderson WI, King JM (1988) Acute pelvic limb paralysis induced by a lumbar fibrocartilaginous embolism in a sow. Cornell Vet. 78(3):231–234PubMed

20.

Neer TM (1992) Fibrocartilaginous emboli. Vet Clin North Am Small Anim Pract. 22(4):1017–1026PubMed

21.

Toro-Gonzalez G, Havarro-Roman L, Roman GC, Cantillo J, Serrano B, Herrera M, Vergara I (1993) Acute ischemic stroke from fibrocartilaginous embolism to the middle cerebral artery. Stroke. 24(5):738–740PubMed

22.

Bots GT, Wattendorff AR, Buruma OJ, Roos RA, Endtz LJ (1981) Acute myelopathy caused by fibrocartilaginous emboli. Neurology. 31(10):1250–1256PubMed

23.

Toro G, Roman GC, Navarro-Roman L, Cantillo J, Serrano B, Vergara I (1994) Natural history of spinal cord infarction caused by nucleus pulposus embolism. Spine. 19(3):360–366PubMed

24.

Han JJ, Massagli TL, Jaffe KM (2004) Fibrocartilaginous embolism-an uncommon cause of spinal cord infarction: a case report and review of the literature. Arch Phys Med Rehabil. 85(1):153–157PubMed

25.

DeFroda SF, Klinge SA (2016) Fat embolism syndrome with cerebral fat embolism associated with long-bone fracture. Am J Orthop (Belle Mead NJ). 45(7):E515–E521PubMed

26.

Taviloglu K, Yanar H (2007) Fat embolism syndrome. Surg Today. 37(1):5–8PubMed

27.

Kwiatt ME, Seamon MJ (2013) Fat embolism syndrome. Int J Crit Illn Inj Sci. 3(1):64–68PubMedPubMedCentral

28.

Prentice D, Ahrens T (1994) Pulmonary complications of trauma. Crit Care Nurs Q. 17(2):24–33PubMed

29.

Sikary AK, Kumar M, Dhaka S, Subramanian A (2018) A rare fatal complication of Llizarov procedure. J Forensic Sci. 63(6):1895–1898PubMed

30.

Kuo K-H, Pan Y-J, Lao Y-J et al (2014) Dynamic MR imaging patterns of cerebral fat embolism: a systemic review with illustrative cases. AJNR Am J Neuroradiol. 35:1052–1057PubMed

31.

Yeap P, Kanodia AK, Main G, Yong A (2015) Role of susceptibility-weighted imaging in demonstration of cerebral fat embolism. BMJ Case Rep 2015:bcr2014207581PubMedPubMedCentral

32.

Bollerslev J (1987) Osteopetrosis. A genetic and epidemiological study. Clin Genet. 31:86–90PubMed

33.

Miyamoto RT, House WF, Brackmann DE (1980) Neurotologic manifestations of the osteopetroses. Arch Otolaryngol. 106:210–214PubMed

34.

Allen HA, Haney P, Rao KC (1982) Vascular involvement in cranial hyperostosis. AJNR Am J Neuroradiol. 3:193–195PubMed

35.

Lerman-Sagie T, Levi Y, Kidron D, Grunebaum M, Nitzan M (1987) Syndrome of osteopetrosis and muscular degeneration associated with cerebro-oculo-facio-skeletal changes. Am J Med Genet. 28:137–142PubMed

36.

Wilms G, Casaer P, Alliet P, Demaerel P, Smet M, Baert AL (1990) Cerebrovascular occlusive complications in osteopetrosis major. Neuroradiology. 32:511–513PubMed

37.

Farre JM, Declambre B (1989) Functional consequences and complications of Paget’s disease. Rev Prat. 39:1129–1136PubMed

38.

Renier JC (1989) What is Paget’s disease? Rev Prat. 39:1104–1108PubMed

39.

Fournie A, Fournie B, Lassoued S (1989) Paget’s disease: errors to be avoided. Rev Prat 39:1143–1146PubMed

40.

David LR, Wilson JA, Watson NE, Argenta LC (1996) Cerebral perfusion defects secondary to simple craniosynostosis. J Craniofac Surg. 7(3):177–185PubMed

41.

Prontera P, Rogaia D, Mencarelli A, Ottaviani V, Sallicandro E, Guercini G, Esposito S, Bersano A, Merla G, Stangoni G (2017) Juvenile Moyamoya and craniosynostosis in a child with deletion 1p32p31: expanding the clinical spectrum of 1p32p31 deletion syndrome and a review of the literature. Int J Mol Sci. 18(9):1998PubMedCentral

42.

Turner LM, Steffensen TS, Leroy J, Gilbert-Barness E (2010) Spondyloepiphyseal dysplasia congenita. Fetal Pediatr Pathol. 29(1):57–62PubMed

43.

Schimke RN, Horton WA, King CR (1971) Chondroitin-6-sulphaturia, defective cellular immunity, and nephrotic syndrome. Lancet. 13:1088–1089

44.

Boerkoel CF, Nowaczyk MJ, Blaser SI, Meschino WS, Weksberg R (1998) (1998). Schimke immunoosseous dysplasia complicated by moyamoya phenomenon. Am J Med Genet. 78(2):118–122PubMed

45.

Ehrich JH, Burchert W, Schirg E, Krull F, Offner G, Hoyer PF, Brodehl J (1995) Steroid resistant nephrotic syndrome associated with spondyloepiphyseal dysplasia, transient ischemic attacks and lymphopenia. Clin Nephrol. 43(2):89–95PubMed

46.

Debopam S, Ramakrishnaiah R (2017) Diffuse carotid arteriosclerosis and stroke in a patient with Schimke immuno-osseous dysplasia. Pediatr Neurol. 71:82–83

47.

Babaei AH, Inaloo S, Basiratnia M (2019) Schimke immuno-osseous dysplasia: a case report. Indian J Nephrol. 29(4):291–294PubMedPubMedCentral

48.

Sparkes RS, Graham CB (1972) Camurati-Engelmann disease. Genetics and clinical manifestations with a review of the literature. J Med Genet 9:73–85PubMedPubMedCentral

49.

Massagué J (1990) The transforming growth factor-beta family. Annu Rev Cell Biol 6:597–641PubMed

50.

Janssens K, Gershoni-Baruch R, Guanabens N, Migone N, Ralstone S, Bonduelle M, Lissens W, Van Maldergem L, Vanhoenacker F, Verbruggen N, Van Hul WI (2000) Mutations in the gene encoding the latency-associated peptide of TGFB1 cause Camurati-Engelmann disease. Nat Genet. 26:273–275PubMed

51.

Campos-Xavier AB, Saraiva JM, Savarirayan R, Verloes A, Feingold J, Faivre L, Munnich A, Le Merrer M, Cormier-Daire V (2001) Phenotypic variability at the TGF-β1 locus in Camurati-Engelmann disease. Hum Genet. 109:653–658PubMed

52.

Cerrato P, Baima C, Bergui M, Grasso M, Lentini A, Azzaro C, Bosco G, Imperiale D, Migone N, Allavena A, Bergamasco B (2005) Juvenile vertebrobasilar ischaemic stroke in a patient with Camurati-Engelmann disease. Cerebrovasc Dis. 20:283–284

53.

Metcalfe JC, Grainger DJ (1995) Transforming growth factor-beta and the protection from cardiovascular injury hypothesis. Biochem Soc Trans. 23:403–406PubMed

54.

Chamberlain J (2001) Transforming growth factor-β: a promising target for antistenosis therapy. Cardiovasc Drug Rev. 19:329–344PubMed

55.

Stickens D, Clines G, Burbee D, Ramos P, Thomas S, Hogue D, Hecht JT, Lovett M, Evans GA (1996) The EXT2 multiple exostoses gene defines a family of putative tumor suppressor genes. Nat Genet. 14:25–32PubMed

56.

Wicklund CL, Pauli RM, Johnston D, Hecht JT (1995) Natural history study of hereditary multiple exostoses. Am J Med Genet. 55:43–46PubMed

57.

Gouicem D, Palcau L, LeHello C, Coffin O, Maiza D, Berger L (2013) Gigantic clavicle osteochondroma with carotid compression as a rare cause of stroke. J Vasc Surg. 57(3):845–847PubMed

58.

Ploumis A, Liampas A, Angelidis M, Theodorou A, Xydis V, Gelalis I, Zampakis P, Panagiotopoulos V (2018) Multiple exostoses syndrome and basilar artery aneurysm: a case report. J Vasc Interv Neurol. 10(2):28–32PubMedPubMedCentral

59.

Schievink WI (2001) Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med. 344(12):898–906PubMed

60.

Dardiotis E, Aloizou AM, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G, Libra M, Kyritsis AP, Brotis AG, Aschner M, Gozes I, Bogdanos DP, Spandidos DA, Mitsias PD, Tsatsakis A (2019) Cancer-associated stroke: pathophysiology, detection and management (Review). Int J Oncol. 54(3):779–796PubMedPubMedCentral

61.

Katz JM, Segal AZ (2005) Incidence and etiology of cerebro-vascular disease in patients with malignancy. Curr Atheroscler Rep. 7:280–288PubMed

62.

Limper AH, Prakash UB, Kokmen E, Callahan MJ (1988) Cardiopulmonary metastatic lesions of osteosarcoma and associated cerebral infarction. Mayo Clin Proc 63(6):592–595PubMed

63.

Mahoney DH, Shuster JJ, Nitschke R, Lauer SJ, Steuber CP, Winick N (1998) Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy – a Pediatric Oncology Group study. J Clin Oncol. 16(5):1712–1722PubMed

64.

Mortazavi SMJ, Kakli H, Bican O, Moussouttas M, Parvizi J, Rothman RH (2010) Perioperative stroke after total joint arthroplasty: prevalence, predictors, and outcome. J Bone Joint Surg Am. 92:2095–2101PubMed

65.

Hart R, Hindman B (1982) Mechanisms of perioperative cerebral infarction. Stroke. 13:766–773PubMed

66.

Vlisides P, Mashour GA (2016) Perioperative stroke. Can J Anaesth. 63(2):193–204PubMed

67.

Minhas SV, Goyal P, Patel AA (2016) What are the Risk Factors for Cerebrovascular Accidents After Elective Orthopaedic Surgery? Clin Orthop Relat Res. 474(3):611–618PubMed

68.

Brooks DC, Schindler JL (2014) Perioperative stroke: risk assessment, prevention and treatment. Curr Treat Options Cardiovasc Med. 16:282PubMed

69.

Rodgers A, Walker N, Schug S, McKee A, Kehlet H, van Zundert A, Sage D, Futter M, Saville G, Clark T, MacMahon S (2000) Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 321:1493–1497PubMedPubMedCentral

70.

Mashour GA, Moore LE, Lele AV, Robicsek SA, Gelb AW (2014) Perioperative care of patients at high risk for stroke during or after non-cardiac, non-neurologic surgery: consensus statement from the Society for Neuroscience in Anesthesiology and Critical Care*. J Neurosurg Anesthesiol. 26(4):273–285PubMed

Titel: Relationship between bone disorders and stroke
verfasst von: Milija D. Mijajlovic
Vuk Aleksic
Natasa Stojanovski
Natan M. Bornstein
Publikationsdatum: 02.10.2020
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 12/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04748-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Relationship between bone disorders and stroke

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2020

Management of antiepileptic drug–induced nutrition-related adverse effects

Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19

MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development

Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study

Application of the p9NORM correction method to timed neuropsychological tests in Parkinson’s disease and multiple system atrophy

COVID-19 presenting with agraphia and conduction aphasia in a patient with left-hemisphere ischemic stroke

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie